Nuventra Pharma Sciences CEO and key executive team

Nuventra Pharma Sciences's President & Chief Executive Officer is Geoffrey Banks. Nuventra Pharma Sciences's key executives include Geoffrey Banks and 24 others.
Geoffrey Banks

Geoffrey Banks

President & Chief Executive Officer
M. Alexander Shaw

M. Alexander Shaw

Chief Operating Officer
Bill Wargin

Bill Wargin

Executive Vice President, Pharmacokinetics
David Y. Mitchell

David Y. Mitchell

Chief Scientific Officer
Mary Barecki-Roach

Mary Barecki-Roach

Vice President, Quality Assurance
Daniel L. G. Roy

Daniel L. G. Roy

Vice President, Corporate Strategy & Business Development
Jessica K. Higgins

Jessica K. Higgins

Associate Director, Programming
Ryan Dackor

Ryan Dackor

Associate Director, Contracts & Proposals
Mark A. Bush

Mark A. Bush

Vice President, Clinical Pharmacology & Pharmacokinetics
Brandon Burch

Brandon Burch

Associate Director, Scientific Writing & Regulatory Affairs
Brianna Collier

Brianna Collier

Associate Director, Human Resources
Scott Brantley

Scott Brantley

Director, Pharmacokinetics
Michael J. Lamson

Michael J. Lamson

Vice President, Clinical Pharmacology & Pharmacokinetics
Kate Moore

Kate Moore

Associate Director, Program Management
Laurie Keilholz

Laurie Keilholz

Director, Program Management
Kelly Gelinne

Kelly Gelinne

Associate Director, Marketing
Gene Williams

Gene Williams

Associate Vice President, Clinical Pharmacology
Elizabeth Hussey

Elizabeth Hussey

Vice President, Clinical Pharmacology & Pharmacokinetics
Jessica D. Mason

Jessica D. Mason

Senior Director, Data Management
John Trang

John Trang

Vice President, Pharmacokinetics
William G. Tracewell

William G. Tracewell

Director, Clinical Pharmacology & Pharmacokinetics
J. Charles

J. Charles

Director, Nonclinical & Clinical Pharmacology
Lori Mixson

Lori Mixson

Senior Director, Biostatistics
Michael Faas

Michael Faas

Director, Information Technology
Tyler Cromer

Tyler Cromer

Scientific Editor
Last updated: